CARUNZAMO
LIVE

Serial Number

79437487

Owner

Miltenyi Biotec B.V. & Co. KG

Attorney

Peter Sloane

Filing Date

Sep 9, 2025

Add to watchlist:

No watchlists yet
View on USPTO

CARUNZAMO Trademark

Serial Number: 79437487 • Registration: 8290341

CARUNZAMO is a trademark filed by Miltenyi Biotec B.V. & Co. KG on September 9, 2025. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently registered and active.

Owner Contact Info

Miltenyi Biotec B.V. & Co. KG

Friedrich-Ebert-Straße 68

Entity Type: 99

Trademark Details

Filing Date

September 9, 2025

Registration Date

June 9, 2026

Published for Opposition

April 21, 2026

Goods & Services

Medical services in the field of extracorporeal plasma therapy; medical treatment services, namely, medical services for the treatment of cancer or autoimmune diseases

Services of medical research, pharmaceutical production, or biotechnological research laboratories; medical and pharmaceutical services, namely services of a medical research and pharmaceutical production laboratory in the fields of cell therapeutic agents, cell compounds, cell preparation, cellular medicines, and the selection, stimulation, and activation of cells

Chemical, biological and biochemical products for industrial, scientific, and diagnostic purposes, namely, chemicals for use in industry and science; chemical diagnostic reagents for industrial and scientific purposes; Biological preparations for use in industry and science; Biological diagnostic preparations for scientific or research use; biochemical preparations for use in industry and science; biochemical diagnostic preparations for scientific or research use; chemical, biological and biochemical products, namely, chemical preparations, biological preparations, and biological preparations for industrial or scientific use in separation processes for biological materials, and not for medical purposes; reagents for cell separation, labeling reagents, reagents, media, substances and ingredients for the preparation of media, namely, chemical reagents for scientific purposes and not for medical purposes; reagents for the processing, separation, isolation, enrichment, depletion, detection, screening, analysis and counting of chemical and biological materials, namely, chemical reagents for scientific purposes and not for medical purposes; chemical reagents with magnetic beads for scientific purposes; antibody reagents used for the detection of antigens in cells and tissue, other than for medical or veterinary purposes; buffer solutions for use in analytical chemistry and chemical reagents for use with laboratory instruments, separation instruments, analysis instruments, reactors and imaging instruments, all for scientific purposes and not for medical purposes; chemical reagents for processing of biological material, biological tissue, bone marrow, cells, blood and its components for scientific purposes and not for medical or veterinary purposes; diagnostic reagents and preparations for scientific purposes and for use in medical research laboratories, other than for medical use; blood culture media, cell culture media, and cell freezing media, all for scientific purposes; chemical reagents for use in biotechnology, in biological treatment processes and in the biotechnology industry, all for scientific or industrial purposes and not for medical purposes

Pharmaceutical preparations for treating cancer and autoimmune diseases; medical preparations for the treatment of for treating cancer and autoimmune diseases; veterinary preparations for treating cancer and autoimmune diseases; Chemical reagents for medical or veterinary purposes; media and materials and ingredients for the preparation of media, all for cell cultures for medical or veterinary purposes; Chemical reagents for the processing, separation, isolation, enrichment, depletion, detection, screening, analysis and counting of biological materials, all for medical or veterinary purposes; chemical reagents with magnetic beads, and antibody reagents used for the detection of antigens in cells and tissue for medical purposes, all for medical or veterinary purposes; reagents for use with medical instruments, separation instruments, analysis instruments, reactor and imaging instruments, for medical purposes; clinical medical reagents for the processing of biological material, biological tissue, bone marrow, cells, blood and its components, all for medical or veterinary purposes; culture media for cultivating human cells; cell culture media, diagnostic reagents and preparations, all for medical and veterinary purposes; cell freezing media, X-ray contrast agents, and contrast agents for in-vivo imaging, all for medical and veterinary purposes; pharmaceutical products for cellular therapy

Filing History

NOTICE OF REGISTRATION CONFIRMATION EMAILED
Jun 9, 2026 NRCC
REGISTERED-PRINCIPAL REGISTER
Jun 9, 2026 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Apr 21, 2026 NPUB
PUBLISHED FOR OPPOSITION
Apr 21, 2026 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Apr 15, 2026 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Mar 26, 2026 CNSA
EXAMINER'S AMENDMENT ENTERED
Mar 26, 2026 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Mar 26, 2026 GNEN
EXAMINERS AMENDMENT E-MAILED
Mar 26, 2026 GNEA
EXAMINERS AMENDMENT -WRITTEN
Mar 26, 2026 CNEA
REFUSAL PROCESSED BY IB
Mar 5, 2026 RFNT
TEAS/EMAIL CORRESPONDENCE ENTERED
Mar 3, 2026 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Mar 3, 2026 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Mar 3, 2026 TROA
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Feb 19, 2026 RFCS
REFUSAL PROCESSED BY MPU
Feb 19, 2026 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Jan 24, 2026 RFCR
NON-FINAL ACTION WRITTEN
Jan 23, 2026 CNRT
ASSIGNED TO EXAMINER
Jan 22, 2026 DOCK
APPLICATION FILING RECEIPT MAILED
Dec 3, 2025 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Dec 3, 2025 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Nov 20, 2025 REPR